IL6 and COVID-19: Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease, which is pandemic, infectious, and high mortality.[1] Remdesivir, hydroxychloroquine, and interleukin-6 (IL-6) pathway inhibitors are some of the most commonly discussed medications being used to treat COVID-19 today, but they are not without potentially harmful side effects or drug interactions.